Dr. Nutan Jyothi Vaz, MD

Dr. Vaz practices at HCA Florida Gulf Coast Hospital in Panama City, Florida, part of HCA Healthcare.

Dr. Vaz's NPI, 1235380643, was assigned on October 3, 2008. Dr. Vaz holds Florida license ME113167.

Dr. Vaz's primary practice is HCA Florida Gulf Coast Hospital, at 449 W 23rd St, Panama City, FL 32405 in Bay County. The practice phone is (850) 747-7926.

Dr. Vaz's primary practice is HCA Florida Gulf Coast Hospital in Panama City, Florida, part of HCA Healthcare. Dr. Vaz is also affiliated with Logan Health Medical Center. The medical group on file is Hospital Physician Services of Florida PA. Dmand AI also links Dr. Vaz to 5 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Vaz practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Vaz's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Vaz's licenses on file in 3 states: Florida, Georgia and North Dakota.

CMS data shows 195 Medicare services from Dr. Vaz across 5 procedure codes in 2024, all of them office visits, for 176 Medicare patients. Medicare paid $14,085 for them. Every service was in an office.

CMS counts 176 Medicare patients who saw Dr. Vaz in 2024. The largest group is 65 to 74, with 92 patients. 74% of them have high blood pressure, and 68% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Vaz's median patient age at 72, with 56% women.

In 2024, Dr. Vaz wrote 52 Medicare Part D claims for 21 patients. 79% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $125 in total drug cost. In 2017, CMS named 396 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Vaz for performance year 2024, reported as part of a group. Dr. Vaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Vaz as offering telehealth.

CMS Open Payments shows 7 general payments to Dr. Vaz from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Abbvie Inc. paid the most, $94.